MYH7 and coronary artery disorder: Mutations in MYH7 that cause Ebstein anomaly also lead to ventricular noncompaction and reduced ventricular function.101 Similarly, multiple studies have shown that CHD patients with sarcomeric mutations have differential clinical outcomes, including reduced ventricular performance and transplant‐free survival.